Advertisement

Topics

PubMed Journals Articles About "Daiichi Pharmaceutical" RSS

21:07 EST 23rd January 2019 | BioPortfolio

Daiichi Pharmaceutical PubMed articles on BioPortfolio. Our PubMed references draw on over 21 million records from the medical literature. Here you can see the latest Daiichi Pharmaceutical articles that have been published worldwide.

More Information about "Daiichi Pharmaceutical" on BioPortfolio

We have published hundreds of Daiichi Pharmaceutical news stories on BioPortfolio along with dozens of Daiichi Pharmaceutical Clinical Trials and PubMed Articles about Daiichi Pharmaceutical for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Daiichi Pharmaceutical Companies in our database. You can also find out about relevant Daiichi Pharmaceutical Drugs and Medications on this site too.

Showing "Daiichi Pharmaceutical" PubMed Articles 1–25 of 1,800+

Atmospheric activity concentration of Sr and Cs after the Fukushima Daiichi Nuclear Accident.

On 11 March 2011, the Fukushima Daiichi Nuclear Power Plant (FDNPP) accident occurred and a large amount of radionuclides were discharged into the atmosphere. We have operated continuous aerosol samplings at four locations in Japan from the accident until the end of 2011. The activities of Sr and Cs in the aerosol samples were measured using low background liquid scintillation counters and high-purity germanium detectors, respectively. The atmospheric 90Sr and 137Cs concentrations decreased exponentially du...


Re: Associations between Childhood Thyroid Cancer and External Radiation Dose after the Fukushima Daiichi Nuclear Power Plant Accident.

IMPACT ON ABSORBED DOSE RATE IN AIR IN THE IZU ISLANDS FROM LONG HALF-LIFE RADIONUCLIDES RELEASED BY THE FUKUSHIMA DAIICHI NUCLEAR POWER PLANT ACCIDENT.

Car-borne surveys were carried out on eight islands of the Izu Islands located 339-570 km southwest of the Fukushima Daiichi Nuclear Power Plant. The mean dose rates measured in 2015, 2016 or 2017 on each island were from 12 to 47 nGy h-1, meaning that the contribution ratios of artificial radionuclides were 5-31%. Based on the environmental half-life for long half-life radionuclides (134Cs + 137Cs) measured on Izu-Oshima (3.1 y), the mean dose rates in March 2011 were estimated to be 15-53 nGy h-1 and the ...


Projecting Pharmaceutical Expenditure in EU5 to 2021: Adjusting for the Impact of Discounts and Rebates.

Within (European) healthcare systems, the predominant goal for pharmaceutical expenditure is cost containment. This is due to a general belief among healthcare policy makers that pharmaceutical expenditure-driven by high prices-will be unsustainable unless further reforms are enacted.

Solid-state insight into the action of a pharmaceutical solvate: structural, thermal and dissolution analysis of indinavir sulfate ethanolate.

The crystal structure of indinavir sulfate, a pharmaceutical administered as an ethanol solvate, is presented, revealing a unique channel/ionic solvate structure to be characteristic of the compound. The properties of the material with regard to thermal treatment and water adsorption follow closely from the structure. The in situ amorphization of the pharmaceutical upon contacting liquid water is observed and highlights the unique dissolution enhancement of marketing the crystalline solvate dosage. Through ...

The relationship between pharmacy benefit managers (PBMs) and the cost of therapies in the US pharmaceutical market: A policy primer for clinicians.

Pharmaceutical benefit managers (PBMs) are playing an increasingly important role in establishing access to pharmaceutical products for patients. PBMs set retail prices for pharmaceutical products, negotiate "rebates" from manufacturers based on total sales volume of products, and achieve several types of postsale price concessions and payments from pharmacies. All of these activities describe a complex flow of funds that has not been transparent to clinicians or to patients. In this article, we describe th...

Fifty-eight Years and Counting: High-Impact Publishing in Computational Pharmaceutical Sciences and Mechanism-based Modeling.

Discussions on the new molecular formula and new molecular entity definitions of pharmaceutical innovation.

Air and waterborne microbiome of a pharmaceutical plant provide insights on spatiotemporal variations and community resilience after disturbance.

The presence of microrganisms in pharmaceutical production plant environments is typically monitored by cultural methods, however these cannot detect the unculturable fraction of the microbial community. To get more accurate information on the composition of these indoor microbial communities, both water and air microbiome from a pharmaceutical production plant were profiled by 16S amplicon sequencing.

Changes in the Soil to Brown Rice Concentration Ratio of Radiocaesium before and after the Fukushima Daiichi Nuclear Power Plant Accident in 2011.

Radiocaesium (Cs) mobility in soil is initially relatively high when the nuclide first comes into contact with soil, after which the mobile fraction decreases with time due to Cs fixation to soil particles (aging effect). Consequently, the Cs activity concentration in plants grown in soil was expected to decrease with time after the Fukushima Daiichi nuclear power plant accident in 2011. In this study, we collated data on concentration ratios (CR) of Cs between brown rice grain and paddy soil and compared C...

Contribution to the Development of Pharmaceutical Education in Six-year and Four-year Programs.

 I joined efforts to promote the pharmaceutical education system by participating in committees for developing a model core curriculum for pharmaceutical sciences (core curriculum), in pharmacist educator workshops, in the development of a pharmaceutical common achievement test, evaluation of pharmaceutical education programs, and the creation of a national examination for pharmacists. This review outlines the efforts to reform these pharmaceutical education systems. The core curriculum was prepared under...

Application of synchrotron radiation and other techniques in analysis of radioactive microparticles emitted from the Fukushima Daiichi Nuclear Power Plant accident-A review.

During the Fukushima Daiichi Nuclear Power Plant (FDNPP) accident, large amounts of radioactive materials were released into the environment. Among them, a large proportion of the radionuclides, such as Cs, entered into the environment as radioactive microparticles (RMs). In recent years, the characterization of RMs based on synchrotron radiation (SR) techniques has been reported, since their physical and chemical properties played an important role in evaluating the chemical reactions and physical changes ...

Pu isotopes in the seawater off Fukushima Daiichi Nuclear Power Plant site within two months after the severe nuclear accident.

The marine environment is complex, and it is desirable to have measurements for seawater samples collected at the early stage after the Fukushima Daiichi Nuclear Power Plant (FDNPP) accident to determine the impact of Fukushima-derived radionuclides on this environment. Here Pu isotopes in seawater collected 33-163 km from the FDNPP site at the very early stage after the accident were determined (May 2011, within two months after the accident). The distribution and temporal variation of Pu and Pu were stu...

Drug Policy in Greece.

To provide a detailed overview of the recent reforms in pharmaceutical pricing and reimbursement processes as well as in other important areas of the pharmaceutical policy in Greece.

Disease awareness advertising (DAA) in emerging economy: A comparison between views of consumers and pharmaceutical professionals.

Research on effectiveness of DAA is limited. Existing researches explore impact of DAA only on relationship between drug manufacturers and consumers. However, in reality, pharma marketing revolves around three major stakeholders: the pharmaceutical companies, physicians and consumers. Pharmaceutical professionals on behalf of drug manufacturers have last mile connectivity with end users and they are an important stakeholder in this entire marketing relationship network. So, it is important for marketers to ...

The Impact of the National Institute for Pharmaceutical Technology and Education on Academic Research.

Surveys of institutional representatives of member institutions and faculty members engaged in the National Institute for Pharmaceutical Technology and Education (NIPTE) revealed that NIPTE is having a positive impact on academic research in the area of pharmaceutical technology by aligning research directions with FDA needs, by providing funding that may not be available elsewhere, and by creating a collegial and collaborative relationship among researchers in this area from various institutions. NIPTE is ...

Twitter use in scientific communication revealed by visualization of information spreading by influencers within half a year after the Fukushima Daiichi nuclear power plant accident.

Scientific communication through social media, particularly Twitter has been gaining importance in recent years. As such, it is critical to understand how information is transmitted and dispersed through outlets such as Twitter, particularly in emergency situations where there is an urgent need to relay scientific information. The purpose of this study is to examine how original tweets and retweets on Twitter were used to diffuse radiation related information after the Fukushima Daiichi nuclear power plant ...

Pharmacokinetic and pharmaceutical properties of a novel buprenorphine/naloxone sublingual tablet for opioid substitution therapy versus conventional buprenorphine/naloxone sublingual tablet in healthy volunteers.

A novel sublingual buprenorphine/naloxone rapidly-dissolving tablet (BNX-RDT) for opioid substitution therapy has been developed for improved bioavailability, rapid disintegration and improved taste masking. We compared the bioavailability and pharmaceutical properties of BNX-RDT with conventional buprenorphine/naloxone sublingual tablets (BNX).

Molecular State of Active Pharmaceutical Ingredients in Ketoprofen Dermal Patches Characterized by Pharmaceutical Evaluation.

The molecular states of ketoprofen and the interaction between ketoprofen and other pharmaceutical excipients in the matrix layer were examined to determine their effect on the pharmaceutical properties of original and generic ketoprofen dermal patches (generic patches A and B). Molecular states of ketoprofen were evaluated using polarized light microscopy, Raman spectroscopy and powder X-ray diffraction. For the original ketoprofen patch, crystalline components were not observed in the matrix layer. Howeve...

A novel insight into fluid bed melt granulation: Temperature mapping for the determination of granule formation with the in-situ and spray-on techniques.

Right filter-selection for phase separation in equilibrium solubility measurement.

Development of injectable liposomes and drug-in-cyclodextrin-in-liposome formulations encapsulating estetrol to prevent cerebral ischemia of premature babies.

A new approach to pharmaceutical pricing based on patients' willingness to pay.

Pharmaceutical pricing is an important and contentious issue in middle- and low-income countries. The present study evaluated a value-based pricing system for estimating the price of Interferon-beta (IFN-β).

Pharmaceutical Policy Reforms to Regulate Drug Prices in Asia Pacific Region: The Case of Australia, China, India, Malaysia, New Zealand, and South Korea.

Medicine price directly affects affordability and access to medicines particularly in countries where a major portion of pharmaceutical spending is through out-of-pocket payment, such as in the Asia Pacific region. We have undertaken a detailed appraisal of the pharmaceutical policy reforms to regulate drug prices in 3 developed (Australia, New Zealand, and South Korea) and 3 emerging (China, India, and Malaysia) economies of the Asia Pacific region. Despite continuous efforts by the authorities in adopting...

Assessment of Pharmaceutical Company and Device Manufacturer Payments to Gastroenterologists and Their Participation in Clinical Practice Guideline Panels.

Payments from pharmaceutical and device manufacturers to physicians may influence the advice physicians give patients and peers.


Advertisement
Quick Search
Advertisement
Advertisement